Tirzepatide

Price range: $75.00 through $110.00

Synthetic dual GIP/GLP-1 receptor agonist peptide, lyophilised, supplied in 10 mg and 20 mg vials for laboratory research.

SKU: N/A Categories: , ,

Description

Tirzepatide is a synthetic 39-amino-acid peptide engineered to bind both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. A fatty diacid side chain is attached to the backbone to extend its half-life in solution, which is one reason it appears frequently in incretin receptor pharmacology literature.

Product Specifications

  • Compound: Tirzepatide
  • Class: Synthetic 39-amino-acid dual incretin receptor agonist peptide
  • Sequence: 39-residue acylated peptide (C20 fatty diacid side chain)
  • Molecular weight: ~4813 Da
  • CAS number: 2023788-19-2
  • Form: Lyophilised powder in a sealed glass vial
  • Available sizes: 10 mg and 20 mg per vial
  • Purity: ≥99% by HPLC — see the certificate of analysis for the batch supplied

Research Background

Tirzepatide is studied in the context of dual incretin receptor signalling. Research literature covers areas such as:

  • Receptor binding and selectivity studies at GIP and GLP-1 receptors
  • Downstream cAMP signalling and beta-cell model systems
  • Comparative studies against single-agonist incretin peptides
  • Peptide acylation and half-life extension chemistry

Peer-reviewed literature on this compound can be searched through PubMed and the NIH PMC database. Troy Peptides supplies reference material only and does not provide research protocols or interpret published findings.

Analytical Verification

Identity and purity are confirmed by independent third-party analysis before release.

  • High-performance liquid chromatography (HPLC) for purity quantification
  • Mass spectrometry (MS) for identity and molecular weight confirmation

A third-party certificate of analysis is available for every product. See Certificates of Analysis.

Handling and Storage

  • Lyophilised material: store cool, dry and away from direct light; −20 °C for long-term storage
  • After reconstitution: refrigerate at 2–8 °C and protect from light
  • Avoid repeated freeze–thaw cycles

Terms of Sale

This product is supplied strictly for in vitro laboratory research. It is not a drug, food or cosmetic, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure or prevent any disease. By purchasing, the buyer confirms that they are at least 21 years of age and a qualified research professional or institution, and that this material will not be used for human consumption, veterinary use or any in vivo application.

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *